Sigma Planning Corp Raises Holdings in Cardinal Health, Inc. $CAH

Sigma Planning Corp increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 42.2% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 9,461 shares of the company’s stock after acquiring an additional 2,810 shares during the period. Sigma Planning Corp’s holdings in Cardinal Health were worth $1,944,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. grew its position in Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after acquiring an additional 150 shares during the period. Aventura Private Wealth LLC purchased a new position in Cardinal Health in the fourth quarter worth approximately $25,000. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the period. JPL Wealth Management LLC purchased a new position in Cardinal Health in the third quarter worth approximately $31,000. Finally, Turning Point Benefit Group Inc. purchased a new position in Cardinal Health in the third quarter worth approximately $31,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an “overweight” rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the “mixed” nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Stock Performance

Cardinal Health stock opened at $195.13 on Friday. The firm has a 50 day moving average price of $213.73 and a 200 day moving average price of $205.82. The company has a market capitalization of $45.92 billion, a PE ratio of 29.84, a price-to-earnings-growth ratio of 1.20 and a beta of 0.53. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Wednesday, April 1st. Cardinal Health’s payout ratio is presently 29.35%.

Analyst Ratings Changes

Several brokerages recently weighed in on CAH. Leerink Partners reiterated an “outperform” rating and issued a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a report on Friday. Barclays lifted their target price on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Monday, April 20th. Finally, Citigroup dropped their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $243.67.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.